B-ENT
Case Report

A Double Intranasal Approach to Treat Cholesteatoma of the Maxillary Sinus: A Report of Two Cases and a Literature Review

1.

Department of Otorhinolaryngology, Tongji Medical College, Huazhong University of Science and Technology, Jie Fang Avenue, Wuhan, China

2.

Department of Otorhinolaryngology, The Eighth Hospital of Wuhan, Wuhan, China

B-ENT 2020; 1: -
DOI: 10.5152/B-ENT.2022.21383
Read: 282 Downloads: 115 Published: 20 May 2022

Cholesteatoma in the maxillary sinus is a rare disease entity and there is not much experience in treating this disease which often leads to recur. Here we report 2 cases of maxillary sinus cholesteatoma and explore its clinical features and surgical approaches in combination with the literature. Our patients underwent endoscopic prelacrimal and natural ostium approaches to completely remove the cholesteatoma. They were followed up for 32 months and 12 months, respectively, without recurrence. This double intranasal approach has the advan- tages of fully exposing each wall of the maxillary sinus, completely removing the lesions, and easy postoperative observation. The double approaches of an endoscopic prelacrimal and a natural ostium could currently be the first choice to remove a maxillary sinus cholesteatoma.

Cite this article as: Zhen H, Peng L, Niu D. A double intranasal approach to treat cholesteatoma of the maxillary sinus: A report of two cases and a literature review. B-ENT 11 May 2022 10.5152/B-ENT.2022.21383 [Epub Ahead of Print]

Files
EISSN 2684-4907